Oceanpine Healthcare Fund is a Beijing based venture capital fund set up for investing in health care and therapeutics in China. The company is investing in early-stage and growth-stage companies that are connecting healthcare innovations in the United States with the consumers in China. It invests in Chinese and US firms with healthcare products and proprietary R&D capabilities. The company focuses on medical devices, biotech, artificial intelligence implementation in the medical sector, innovative drug discovery, genome sequencing, and in-vitro diagnosis (IVD).
Dr. Hai Yan
Dr. Michael Yuanjie Zhang
Investment Committee Advisor
Dr. Ralph Weichselbaum
Chairman of Medical Advisory Committee